“This trial should put a halt to routine screening and treatment of subclinical hypothyroidism during pregnancy,” Peaceman said. “The result will be not only less intervention and cost, but also less anxiety for pregnant women about having a condition that needs treatment.”
“This trial should put a halt to routine screening and treatment of subclinical hypothyroidism during pregnancy,” Peaceman said. “The result will be not only less intervention and cost, but also less anxiety for pregnant women about having a condition that needs treatment.”
ReplyDelete